These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17207311)

  • 1. Clinical trials using chemopreventive vitamin D analogs in breast cancer.
    Vijayakumar S; Boerner PS; Mehta RR; Packianathan S; Mehta RG; Das Gupta TK
    Cancer J; 2006; 12(6):445-50. PubMed ID: 17207311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials involving vitamin D analogs in prostate cancer.
    Vijayakumar S; Mehta RR; Boerner PS; Packianathan S; Mehta RG
    Cancer J; 2005; 11(5):362-73. PubMed ID: 16259866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D analogs and breast cancer.
    O'Kelly J; Koeffler HP
    Recent Results Cancer Res; 2003; 164():333-48. PubMed ID: 12899532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D in cancer chemoprevention.
    Giammanco M; Di Majo D; La Guardia M; Aiello S; Crescimannno M; Flandina C; Tumminello FM; Leto G
    Pharm Biol; 2015; 53(10):1399-434. PubMed ID: 25856702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D and breast cancer: emerging concepts.
    Mehta RG; Peng X; Alimirah F; Murillo G; Mehta R
    Cancer Lett; 2013 Jun; 334(1):95-100. PubMed ID: 23142286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D and cancer].
    Yamana K; Saito H; Takenouchi K; Azuma Y; Ishizuka S
    Clin Calcium; 2006 Jul; 16(7):1147-53. PubMed ID: 16816475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and vitamin D analogs as cancer chemopreventive agents.
    Guyton KZ; Kensler TW; Posner GH
    Nutr Rev; 2003 Jul; 61(7):227-38. PubMed ID: 12918875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current progress in using vitamin D and its analogs for cancer prevention and treatment.
    Cheung FS; Lovicu FJ; Reichardt JK
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):811-37. PubMed ID: 22716497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolites and/or analogs: which D for which patient?
    Mazzaferro S; Goldsmith D; Larsson TE; Massy ZA; Cozzolino M
    Curr Vasc Pharmacol; 2014 Mar; 12(2):339-49. PubMed ID: 23713876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells.
    Pirianov G; Colston KW
    Steroids; 2001; 66(3-5):309-18. PubMed ID: 11179739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of vitamin D in the prevention and the additional therapy of cancers].
    Speer G
    Magy Onkol; 2010 Dec; 54(4):303-14. PubMed ID: 21163761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemoprevention using natural vitamin D and synthetic analogs.
    Guyton KZ; Kensler TW; Posner GH
    Annu Rev Pharmacol Toxicol; 2001; 41():421-42. PubMed ID: 11264464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and vitamin D analogs in cancer treatment.
    van den Bemd GJ; Chang GT
    Curr Drug Targets; 2002 Feb; 3(1):85-94. PubMed ID: 11899952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D-3 receptor as a target for breast cancer prevention.
    Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
    J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and intervention trials in prostate cancer: from theory to therapy.
    Schwartz GG
    Ann Epidemiol; 2009 Feb; 19(2):96-102. PubMed ID: 18619854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer.
    Rossdeutscher L; Li J; Luco AL; Fadhil I; Ochietti B; Camirand A; Huang DC; Reinhardt TA; Muller W; Kremer R
    Cancer Prev Res (Phila); 2015 Feb; 8(2):120-8. PubMed ID: 25468832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics underpins novel clues on VDR chemoprevention target in breast cancer.
    Muti P; Benassi B; Falvo E; Santoro R; Galanti S; Citro G; Carrubba G; Blandino G; Strano S
    OMICS; 2011 Jun; 15(6):337-46. PubMed ID: 21348760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.